Cynthia Herdrich received medical care through an HMO-style arrangement in which her primary care physicians were shareholders in a clinic affiliated with the HMO. After she developed abdominal pain, her physician suspected appendicitis and recommended an ultrasound. Instead of ordering an immediate test at a nearby non-HMO hospital, the physician scheduled the procedure for eight days later at a facility owned or affiliated with the HMO, citing plan protocols and cost-containment practices. During the delay, Herdrich's appendix ruptured, causing peritonitis and serious complications. Herdrich sued her physician and related entities in state court for medical malpractice and fraud, and also brought a federal claim under ERISA asserting that the HMO's financial incentives (tying physician compensation or clinic profits to limiting referrals and keeping care in-network) induced physicians to make medical and coverage decisions that breached ERISA fiduciary duties owed to plan participants. The district court rejected the ERISA fiduciary theory, but the Seventh Circuit allowed it to proceed, concluding that the physician's incentive-influenced decision to delay treatment combined eligibility and treatment elements and could constitute a fiduciary breach under ERISA. The Supreme Court granted certiorari.
Do HMO physicians' mixed eligibility-and-treatment decisions, allegedly influenced by cost-containment incentives, constitute fiduciary acts under ERISA such that a plan participant may sue for breach of fiduciary duty?
Under ERISA, a person is a fiduciary only to the extent they perform functions described in 29 U.S.C. § 1002(21)(A)—exercising discretionary authority or control over plan management or assets, or having discretionary authority or responsibility in plan administration. Medical treatment decisions by treating physicians—even when intertwined with benefit eligibility considerations (i.e., mixed eligibility-and-treatment decisions) and influenced by HMO cost-containment incentives—are not fiduciary acts within the meaning of ERISA. ERISA's fiduciary duty provisions therefore do not provide a cause of action to challenge the structure of HMO physician incentives or to relabel malpractice-type claims as federal fiduciary breaches.
No. Mixed eligibility-and-treatment decisions by HMO physicians are not fiduciary acts under ERISA. Consequently, ERISA does not authorize a fiduciary-duty claim attacking HMO cost-containment incentives or physician decision-making of this type. The judgment of the court of appeals was reversed.
1) Statutory text and capacity: ERISA's fiduciary definition is functional and limited—one is a fiduciary only "to the extent" one exercises plan-management or administrative discretion. Treating physicians, when diagnosing and recommending care, are acting as medical providers, not as plan administrators or asset managers. Even when those clinical judgments incidentally determine whether certain benefits will be used (or where they will be obtained), the physician's role remains principally medical, outside ERISA's fiduciary scope. 2) Mixed eligibility-and-treatment decisions: The Court recognized that many HMO decisions are "mixed," blending coverage eligibility with clinical judgment (e.g., whether to authorize a particular test at a given facility). Classifying all such decisions as fiduciary acts would collapse the distinction between treatment and plan administration, sweeping virtually all medical negligence arising in managed care into ERISA and transforming malpractice into a federal fiduciary-duty regime—an outcome Congress did not intend. 3) Congressional accommodation of HMOs and incentives: HMOs lawfully ration care through physician incentives—including capitation, withhold pools, or ownership interests—to control costs. If incentive-influenced mixed decisions could be deemed fiduciary breaches, the practical effect would be to outlaw commonplace HMO structures or to federalize malpractice claims against them. The Court found no textual or structural support in ERISA for such a dramatic reordering and presumed Congress's awareness and acceptance of managed-care incentives at the time ERISA was enacted and later amended. 4) Federalism and remedial structure: ERISA provides express remedies for benefits denials (e.g., § 502(a)(1)(B)) and fiduciary breaches in plan management, but it does not create a general federal malpractice action. Historically, negligent medical care is policed by state tort law. Preserving that allocation avoids converting routine clinical disputes into ERISA fiduciary litigation. Patients remain free to pursue state malpractice claims, while ERISA continues to govern plan administration and benefits determinations. 5) Administrability: Attempting to dissect mixed decisions into fiduciary and nonfiduciary components would be unworkable and would invite expansive litigation whenever an HMO physician's medical judgment had cost implications. A clear line—treating medical decision-making (even when intertwined with eligibility) as non-fiduciary—maintains administrability and respects ERISA's limited scope.
Pegram is a landmark in ERISA jurisprudence and managed-care law. It establishes that ERISA does not federalize medical malpractice or serve as a vehicle for broad challenges to HMO incentive structures. The decision's articulation of "mixed eligibility-and-treatment decisions" guides courts in distinguishing between plan-administration disputes (potentially remediable under ERISA, e.g., pure benefit denials) and clinical negligence (typically remediable under state law). For students, the case is crucial for understanding ERISA's fiduciary boundaries, the interplay between federal benefits law and state tort law, and the policy rationale for preserving HMOs' cost-containment mechanisms within a system that still permits state malpractice claims.
Pegram v. Herdrich marks a clear boundary line in health benefits litigation: ERISA governs plan administration and fiduciary management, not the substance of medical care decisions rendered by HMO physicians, even when those decisions have benefit implications or reflect cost-containment incentives. By rejecting fiduciary-duty liability for mixed eligibility-and-treatment decisions, the Court preserved the traditional state-law regime for addressing negligent medical care.